Catecholamines and Pituitary Function. VI. Effect of Different Dopamine Doses on TRH-Induced Prolactin Release in Women with Pathological Hyperprolactinemia

The present study was designed to examine the effect of low-dose dopamine (DA) infusion rates (0.02 and 0.1 microgram/kg X min) on both basal and TRH-stimulated prolactin release in normal and hyperprolactinemic individuals. Sixteen normally menstruating women in the early follicular phase of a cycle and 23 hyperprolactinemic patients were studied. 0.1 microgram/kg X min DA was infused in 8 normal women and 15 patients with pathological hyperprolactinemia, while 8 normal controls and 8 patients received 0.02 microgram/kg X min DA TRH (200 micrograms, i.v.) was administered alone and at the 180th min of the 5-hour DA infusion in all controls and patients. A significant reduction in serum PRL levels, which was similar in normal women (-59.5 +/- 4.0%, mean +/- SE) and hyperprolactinemic patients (-48.2 +/- 5.5) was observed in response to 0.1 microgram/kg X min DA. In normal cycling women DA infusion significantly (P less than 0.02) reduced the PRL response to TRH with respect to the basal TRH test (delta PRL 45.0 +/- 7.0 vs. 77.9 +/- 15.4 ng/ml). On the contrary, the PRL response to TRH was significantly higher during 0.1 microgram/kg X min DA than in basal conditions in hyperprolactinemic patients, both in absolute (delta PRL 91.8 +/- 17.6 vs. 38.4 +/- 6.8, P less than 0.03) and per cent (198.5 +/- 67.6 vs. 32.1 +/- 7.5, P less than 0.02) values. A normal PRL response to TRH, arbitrarily defined as an increase greater than 100% of baseline, was restored in 11 out of 15 previously unresponsive hyperprolactinemic patients.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Roberts,et al.  Prolactin-secreting adenomas in women. VII. Dopamine regulation of prolactin secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[2]  F. Peillon,et al.  Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas. , 1983, The Journal of clinical endocrinology and metabolism.

[3]  L. Frohman,et al.  Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia. , 1983, The Journal of clinical endocrinology and metabolism.

[4]  O. Serri,et al.  Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects. , 1983, The Journal of clinical endocrinology and metabolism.

[5]  D. Sarkar,et al.  Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors. , 1982, Science.

[6]  G. Maira,et al.  Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery. , 1982, Metabolism: clinical and experimental.

[7]  P. Plotsky,et al.  Interactions of dopamine and thyrotropin-releasing hormone in the regulation of prolactin release in lactating rats. , 1982, Endocrinology.

[8]  D. Cocchi,et al.  Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations. , 1982, Endocrinology.

[9]  J. D. Neill,et al.  The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro. , 1981, Endocrinology.

[10]  P. Woolf,et al.  Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. , 1981, The American journal of medicine.

[11]  I. Nicoletti,et al.  Progesterone positive feedback on gonadotropin release in estrogen-primed postmenopausal women: central nervous system and pituitary as possible sites of action. , 1981, The Journal of clinical endocrinology and metabolism.

[12]  P. Plotsky,et al.  Dopamine in hypophysial stalk blood of the rhesus monkey and its role in regulating prolactin secretion. , 1981, Endocrinology.

[13]  M. Meschia,et al.  EFFECT OF DOPAMINE INFUSION ON SERUM PROLACTIN CONCENTRATION IN NORMAL AND HYPERPROLACTINAEMIC SUBJECTS , 1980, Clinical endocrinology.

[14]  S. Yen,et al.  Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma. , 1980, The Journal of clinical endocrinology and metabolism.

[15]  L. Peters,et al.  Dopamine in hypophysial portal blood: relationship to circulating prolactin in pregnant and lactating rats. , 1980, Endocrinology.

[16]  J. C. Porter,et al.  Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration. , 1980, Endocrinology.

[17]  J. C. Porter,et al.  Secretion of dopamine into hypophysial portal blood by rats bearing prolactin-secreting tumors or ectopic pituitary glands. , 1979, Endocrinology.

[18]  D. Ayalon,et al.  THE DIAGNOSTIC VALUE OF PHARMACODYNAMIC TESTS IN THE HYPERPROLACTINAEMIC SYNDROME , 1979, Clinical endocrinology.

[19]  M. Rodríguez-Arnao,et al.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin , 1979, Journal of endocrinological investigation.

[20]  P. Woolf,et al.  Dopamine affects basal and augmented pituitary hormone secretion. , 1978, The Journal of clinical endocrinology and metabolism.

[21]  G. L. Noel,et al.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. , 1977, The New England journal of medicine.

[22]  S. Yen,et al.  Effects of dopamine infusion on pituitary hormone secretion in humans. , 1976, The Journal of clinical endocrinology and metabolism.

[23]  G. Burrow,et al.  Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. , 1975, The Journal of clinical endocrinology and metabolism.

[24]  I. Nicoletti,et al.  Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea. , 1984, Hormone research.

[25]  I. Nicoletti,et al.  Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia. , 1984, Hormone research.

[26]  G. Smythe,et al.  Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism. , 1984, The Journal of clinical endocrinology and metabolism.

[27]  K. Kovacs,et al.  Pituitary prolactin cell hyperplasia. , 1980, Hormone research.